Jurors continued Deliberating Friday in the latest Vioxx trial even as legal experts said Merck amp Co.'s defense against thousands of similar lawsuits would be hurt by the accusation that company scientists downplayed the pain Reliever's heart attack risk.
Jurors deliberate Vioxx case as medical Journal causes stir.